Ivosidenib (AG-120) in mutant IDH1 relapsed/refractory acute myeloid leukemia: Results of a phase 1 study Meeting Abstract
| Authors: | DiNardo, C. D.; Stein, E. M.; de Botton, S.; Roboz, G. J.; Altman, J. K.; Mims, A. S.; Swords, R.; Collins, R. H.; Mannis, G. N.; Pollyea, D. A.; Donnellan, W.; Fathi, A. T.; Pigneux, A.; Erba, H. P.; Prince, G. T.; Stein, A. S.; Uy, G. L.; Foran, J. M.; Traer, E.; Stuart, R. K.; Arellano, M. L.; Slack, J. L.; Sekeres, M. A.; Willekens, C.; Choe, S.; Wang, H.; Zhang, V.; Yen, K. E.; Kapsalis, S. M.; Yang, H.; Dai, D.; Fan, B.; Goldwasser, M.; Liu, H.; Agresta, S.; Wu, B.; Attar, E. C.; Tallman, M. S.; Stone, R. M.; Kantarjian, H. M. |
| Abstract Title: | Ivosidenib (AG-120) in mutant IDH1 relapsed/refractory acute myeloid leukemia: Results of a phase 1 study |
| Meeting Title: | 6th Annual Meeting of the Society of Hematologic Oncology (SOHO 2018) |
| Keywords: | clinical trial; acute myeloid leukemia; relapsed aml; ag-120; ivosidenib |
| Journal Title: | Clinical Lymphoma, Myeloma and Leukemia |
| Volume: | 18 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2018 Sep 12-15 |
| Meeting Location: | Houston, TX |
| ISSN: | 2152-2650 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2018-09-01 |
| Start Page: | S204 |
| End Page: | S205 |
| Language: | English |
| ACCESSION: | WOS:000444343400108 |
| DOI: | 10.1016/j.clml.2018.07.057 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: AML-221 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work